Paraffin or shockwaves: which eases carpal tunnel pain best?
NCT ID NCT07167667
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looks at two different physiotherapy treatments—paraffin baths and shockwave therapy—for people with carpal tunnel syndrome. Researchers will measure nerve thickness, nerve activity, pain levels, and quality of life in 60 adults aged 30-60. The goal is to see which treatment offers more relief.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- paraffin bath and extracorporeal shock wave therapy
- What this could lead to
- If this study shows one therapy works better, it could point toward a more effective non-surgical treatment for carpal tunnel syndrome.
- What could go wrong
- This is a small, observational study with only 60 participants, so results may not apply to everyone. It compares existing treatments, not a new breakthrough.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARPAL TUNNEL SYNDROME (CTS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Baltalimani Metin Sabanci Bone Diseases Training and Research Hospita
RECRUITINGIstanbul, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can sound waves or nerve glides ease carpal tunnel pain?
- Can a stem-cell wrap boost nerve repair after carpal tunnel surgery?
- Could a common hand condition reveal hidden heart disease? new imaging trial investigates
- Laser light may help heal nerves in carpal tunnel syndrome
- AI mouse could give Pain-Free computing to millions with hand injuries
- Laser or magnets for wrist pain? study pits new therapies against standard care